drugdeliverybusiness8h
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
wusf15h
Schools aren’t as plugged in as they should be to kids’ diabetes tech, parents say
With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick.
Managed Healthcare Executive16h
Continuous Glucose Monitors Predict Type 1 Diabetes Complications
In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.
Glucotrack, Inc. Announces 1-for-20 Reverse Stock Split
Glucotrack, Inc. (Nasdaq: GCTK) disclosed a significant move within its capital structure. This Delaware corporation specializing in medical devices made public a press release involving a 1-for-20 ...